(ARQT) Arcutis - Performance 69.2% in 12m
Compare ARQT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-32.88%
#49 in Group
Rel. Strength
93.99%
#479 in Universe
Total Return 12m
69.15%
#14 in Group
Total Return 5y
-49.57%
#56 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -6.90%
56th Percentile in Group
12m Total Return: ARQT (69.2%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ARQT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARQT
Total Return (including Dividends) | ARQT | XBI | S&P 500 |
---|---|---|---|
1 Month | 1.69% | 11.81% | 13.81% |
3 Months | 16.61% | -13.61% | -6.30% |
12 Months | 69.15% | -12.29% | 10.65% |
5 Years | -49.57% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | ARQT | XBI | S&P 500 |
1 Month | 55.1% | 72.9% | 83% |
3 Months | 35.9% | -83% | -75.3% |
12 Months | 83.7% | -51.6% | 50.1% |
5 Years | -83.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #161 | -9.04% | -10.7% |
3 Month | #21 | 35.0% | 24.5% |
12 Month | #15 | 92.9% | 52.9% |
5 Years | #56 | -32.9% | -75.7% |
FAQs
Does ARQT Arcutis outperforms the market?
Yes,
over the last 12 months ARQT made 69.15%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ARQT made 16.61%, while XBI made -13.61%.
Over the last 3 months ARQT made 16.61%, while XBI made -13.61%.
Performance Comparison ARQT vs Indeces and Sectors
ARQT vs. Indices ARQT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -8.93% | -12.1% | 29.9% | 58.5% |
US NASDAQ 100 | QQQ | -9.12% | -15.7% | 29.6% | 57.5% |
US Dow Jones Industrial 30 | DIA | -9.34% | -8.30% | 30.1% | 61.4% |
German DAX 40 | DAX | -8.91% | -13.3% | 3.58% | 43.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | -11.1% | -10.1% | 29.1% | 61.8% |
Hongkong Hang Seng | HSI | -12.1% | -18.2% | 21.5% | 55.5% |
India NIFTY 50 | INDA | -4.01% | -3.15% | 29.4% | 69.4% |
Brasil Bovespa | EWZ | -9.98% | -15.6% | 21.2% | 77.5% |
ARQT vs. Sectors ARQT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -9.57% | -11.7% | 22.8% | 47.6% |
Consumer Discretionary | XLY | -9.31% | -12.5% | 30.8% | 54.9% |
Consumer Staples | XLP | -8.07% | -4.90% | 22.9% | 60.0% |
Energy | XLE | -8.75% | -5.07% | 36.4% | 78.6% |
Financial | XLF | -10.0% | -11.8% | 22.8% | 46.7% |
Health Care | XLV | -5.92% | 0.82% | 34.8% | 73.2% |
Industrial | XLI | -10.6% | -15.1% | 28.4% | 58.2% |
Materials | XLB | -8.73% | -11.9% | 34.7% | 74.4% |
Real Estate | XLRE | -7.61% | -9.85% | 29.1% | 53.7% |
Technology | XLK | -10.0% | -19.5% | 32.7% | 62.1% |
Utilities | XLU | -8.98% | -7.90% | 22.2% | 51.7% |
Aerospace & Defense | XAR | -10.9% | -19.5% | 18.4% | 41.8% |
Biotech | XBI | -2.34% | -10.1% | 50.0% | 81.4% |
Homebuilder | XHB | -9.40% | -9.79% | 43.0% | 76.7% |
Retail | XRT | -10.8% | -13.0% | 34.1% | 70.6% |